<DOC>
	<DOCNO>NCT01164436</DOCNO>
	<brief_summary>The incidence lymphoma increase among HIV infect patient . In 70 % case , Non Hodgkin 's lymphoma ( NHL ) Hodgkin lymphoma ( HL ) 30 % case . In France , incidence estimate 100 case per year ( data `` Base de données Hospitalière Française sur l'Infection à VIH '' ( FHDH ) ) . The main mechanism involve lymphomagenesis immune dysfunction , involvement oncogenic virus ( Epstein-Barr ( EBV ) HHV8 ) molecular oncogenic event . A good understanding different pathway , give possibility design specific treatment . The treatment lymphoma standardize . A prospective study patient HIV associate lymphoid malignancy innovate tool answer epidemiological , physiopathological therapeutic question . We propose prospective multicentric study patient . The main objective prospective study : - evaluate incidence , characterise clinically histologically NHL HL case associate HIV - perform observational study treatment outcome patient context clinical trial , - study differentiation activation B-cell population , - well understand role specific T cell response control EBV infection , - allow biological study ANRS group `` Lymphome et VIH `` . The recruitment 40 case per year expect . The length inclusion 7 year . The follow-up 2 year . Clinical , pathological biological data diagnosis follow-up collect . This allow characterizing lymphoma , HIV infection , antitumoral treatment outcome lymphoma . Biological sample centralize collect cell , DNA , RNA , plasma , serum tumour collection ( Y.Taoufik , S Prevot* ) . To good understand EBV infection lymphomagenesis HIV infection , propose follow viral load molecular characteristic EBV PBMC , plasma tumour ( P.Morand* , V.Boyer* ) , investigate EBV-T cell response ( G.Carcelain ) presence reactivation EBV peripheral B cell ( C.Amiel* , JC Nicolas ) tumoral sample ( M.Raphael* , I.Joab* ) . The mechanisms lymphomagenesis HIV infection study analysis sub-populations B-cells term activation differentiation ( Y.Taoufik ) characterization MSI tumour ( A.Duval ) .</brief_summary>
	<brief_title>Cohort HIV Associated Lymphomas</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Lymphoma , AIDS-Related</mesh_term>
	<criteria>Male female patient 18 year age patient HIV1 2 infection Non Hodgkin 's lymphoma ( NHL ) Hodgkin lymphoma ( HL ) diagnosis relapse sign inform consent patient suffer acute leukemia patient treat lymphoïd blood disease Patients whose lymphomas treatment stop less 3 month unaffiliated social healthy security french system</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>